AstraZeneca: Q1 2015 Results (AstraZeneca) - Apr 27, 2015 - Anticipated enrollment completion in P1/2 trial (NCT02205333) in advanced malignancies in Q3 2016; Anticipated top-line data from P1/2 trial (NCT02205333) in advanced malignancies in Q1 2017
Anticipated enrollment status • Anticipated P1/2 data • Oncology
|